Michael Truett Tate - Nov 14, 2024 Form 4 Insider Report for Astera Labs, Inc. (ALAB)

Role: Chief Financial Officer
Signature: /s/ Philip Mazzara, Attorney-in-Fact
Stock symbol: ALAB
Transactions as of: Nov 14, 2024
Transactions value $: $21,236
Form type: 4
Date filed: 11/18/2024, 04:38 PM
Previous filing: Oct 11, 2024
Next filing: Nov 20, 2024

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ALAB	Common Stock	Award	$21.2K	+694	+0.24%	$30.60	294K	Nov 14, 2024	Direct	F1
holding	ALAB	Common Stock						1.76M	Nov 14, 2024	By Tate Trust	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	These shares were acquired under the Astera Labs, Inc. 2024 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c).
F2	These shares are owned directly by Michael T Tate and Jeanne Larue Tate as Trustees of the Tate 1997 Living Trust Dated April 24, 1997 (the "Tate Trust"), of which the Reporting Person is a trustee. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.

Content

These shares were acquired under the Astera Labs, Inc. 2024 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c).

These shares are owned directly by Michael T Tate and Jeanne Larue Tate as Trustees of the Tate 1997 Living Trust Dated April 24, 1997 (the "Tate Trust"), of which the Reporting Person is a trustee. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.